Co-authored by Sheena Wang and Ellie Purnell of HGF limited, “CRISPR and Agriculture” was originally published by Food and Drink
Continue Reading CRISPR and Agriculture
Co-authored by Sheena Wang and Ellie Purnell of HGF limited, “CRISPR and Agriculture” was originally published by Food and Drink …
Continue Reading CRISPR and AgricultureOur current food system is facing a myriad of critical challenges. The United Nations predicts that the world population will…
Continue Reading The Future of Food: Regulatory and Patent Landscape of Genome Editing in Food TechnologyIn a long-awaited milestone in the gene therapy space, the Food and Drug Administration (FDA) approved two gene therapies to…
Continue Reading Gene Therapy Approvals Gain Steam in 2023: FDA Approves First Gene Therapies for Sickle Cell DiseaseGene therapy is part of a new wave of medicine that approaches disease treatment by addressing the root causes rather…
Continue Reading Gene Therapy Approvals Gain Steam in 2023: Milestones in Second Half Pave Way for Transformative 2024Gene therapies have been the subject of tremendous scientific research and investment. With hundreds of clinical trials in progress and…
Continue Reading The Evolving Gene Editing Landscape: From Research Tool to MarketOn February 28, 2022, the Patent Trial and Appeal Board (PTAB) issued a decision in Interference No. 106,115, which granted…
Continue Reading PTAB Sides with Broad in Patent Dispute over CRISPR Gene Editing of Eukaryotic Cells
Vertex Pharmaceuticals and Mammoth Biosciences, a Brisbane, California-based genetic research company, announced a new collaboration for the development of in …
Continue Reading Vertex and Mammoth Biosciences Ink $700M Deal for Ultra-Small CRISPR Systems
Caribou Biosciences, Inc., a Berkeley, California-based CRISPR genome-editing biopharmaceutical company, raised $304M in an initial public offering, one of the…
Continue Reading Caribou Biosciences Raises $304M in Potentially the Largest Gene Editing IPO
On July 13, 2021, Prime Medicine, a Massachusetts biotech company developing next generation gene editing technology, emerged from stealth mode…
Continue Reading Prime Medicine Emerges with $315 Million to Develop Next Generation Gene Editing Platform
We use cookies to enhance your user experience. By continuing to use this site you are giving your consent for us to use cookies. For more information, please see our Privacy Policy.